Indexed in Journament

japanese journal of clinical oncology

ISSN 1465-3621· EN

Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
33.7 / 100
Journament Score
Poor
Ranked #11,074 of 29,305 scored journals (34,041 indexed)
28 Articles
Scores higher than 62.2% of scored journals
050100
The Journament Score is computed from platform statistics — reader engagement, accessibility, publication timeliness, keyword breadth, community impact and content distribution — into a single 0–100 figure, recalculated as new articles and metadata are indexed. Dimensions that cannot be measured for this journal are excluded rather than estimated. It is independent of the paid AI Quality Analysis, which never affects this score or the ranking. Full methodology →

About This Journal

Short Name jpn j clin oncol
Abbreviated Name jpn j clin oncol
ISSN 1465-3621

Quality Profile

6 of 12 dimensions measured
Engagement 31.3
Timeliness 80.0
Diversity 16.7
Innovation 40.5
Community Impact 8.6
Content Distribution 25.6
This journal Average of scored journals
Platform statistics — the free Journament Score AI Quality Analysis — separate paid product, ranks nothing

6 of the 12 dimensions could not be measured for this journal. They are left out entirely rather than plotted as zero, and with 6 dimensions measured there is not enough of a profile to draw as a shape.

Show the numbers
Dimension This journal Corpus average
Engagement 31.3 30.6
Accessibility — 23.6
Timeliness 80.0 3.1
Diversity 16.7 25.9
Innovation 40.5 24.1
Community Impact 8.6 7.0
Content Distribution 25.6 89.9
Content Quality — 55.1
Ethics & Transparency — 40.5
Editorial Standards — 33.0
Publication Regularity — 52.9
Geographic Reach — 30.4

Publications Per Year

Articles (28)

2017
Leptomeningeal metastases of lung adenocarcinoma detected by 18F-FDG PET/CT.
Uslu Biner, Inci;Tatci, Ebru;Erdogan, Yurdanur;Demirag, Funda;Ozmen, Ozlem;
Vol. 47 , No. 9 , pp. 883-884
516 views DOI
2019
Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study.
Motoo, Nagane;Hayashi, Yasuko;Shimizu, Ayaka;Ura, Masako;Nishikawa, Ryo;
Vol. 49 , No. 11 , pp. 1016-1023
456 views DOI Abstract
2020
Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors.
Ryu, Jai Min;Nam, Seok Jin;Kim, Seok Won;Lee, Jeong Eon;Chae, Byung Joo;Lee, Se Kyung;Yu, Jonghan;
427 views DOI Abstract
2019
Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in Japan.
Akaza, Hideyuki;Kurihara, Ryohei;Katsura, Aiko;Harumiya, Miki;Ushida, Naoko;
422 views DOI Abstract
2020
Radiotherapy for local recurrence of non-small-cell lung cancer after lobectomy and lymph node dissection-can local recurrence be radically cured by radiation?
Terada, Yukihiro;Isaka, Mitsuhiro;Harada, Hideyuki;Konno, Hayato;Kojima, Hideaki;Mizuno, Tetsuya;Murayama, Shigeyuki;Takahashi, Toshiaki;Ohde, Yasuhisa;
418 views DOI Abstract
2019
Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
Fei, Zhaodong;Qiu, Xiufang;Li, Mengying;Chen, Chuanben;Li, Yi;Huang, Yingying;
413 views DOI Abstract
2010
Primitive neuroectodermal tumors of adrenal gland.
Zhang, Yushi;Li, Hanzhong;
Vol. 40 , No. 8 , pp. 800-4
365 views DOI Abstract
2019
Issues associated with medical tourism for cancer care in Japan.
Awano, Nobuyasu;Takamoto, Takeshi;Kawakami, Junko;Genda, Atsuko;Ninomiya, Akiko;Ikeda, Misato;Matsuno, Fumie;Izumo, Takehiro;Kunitoh, Hideo;
Vol. 49 , No. 8 , pp. 708-713
363 views DOI Abstract
2026
Identification of a prognostic signature based on expression of post-translational modification-related genes in acute myeloid leukemia
Donghui Gan, Jinfang Zeng, Jun Lin, Xiaojun Chen, Mengting Huang, Dan Weng, Jun Yan
63 views DOI Abstract
2026
Nomogram of conditional survival probability in oldest old patients with colorectal cancer after surgical resection: a multicenter retrospective cohort study
Kiyoaki Sugiura, Eiki Sato, Junya Aoyama, Norihiro Kishida, Hiroto Kikuchi, Koji Okabayashi, Satoshi Aiko, Yuko Kitagawa
62 views DOI Abstract
2026
Northward shift in cancer mortality inequality across Japanese prefectures, 1995–2023, a nationwide ecological study
Hasan Jamil, Aminu Kende Abubakar, Hirokazu Tanaka, Kota Katanoda
13 views DOI Abstract
2026
Comparison of first-line treatment strategies for metastatic hormone-sensitive prostate cancer in Japanese clinical practice since 2020: a multicenter registry study
Takashi Ueda, Keita Hayakawa, Yuki Ota, Junki Murashita, Hikaru Takahashi, Yumiko Saito, Masatsugu Miyashita, Takumi Shiraishi, Atsuko Fujihara, Masayoshi Okumi, Yuta Asakawa, Yuki Harada, Takeshi Yamada, Osamu Ukimura
11 views DOI Abstract
2026
Impact of caseload-threshold centralization of intensity-modulated radiotherapy on cancer care regions in Japan: a nationwide ecological geospatial study
Yuki Egashira, Ryo Watanabe
16 views DOI Abstract
2026
A randomized phase III study optimizing adjuvant osimertinib for resected EGFR -mutant stage II–III non-squamous non-small cell lung cancer: OASIS trial (JACTOP-01)
Ken Onodera, Yoshinori Okada, Yujin Kudo, Masaya Yotsukura, Keisuke Asakura, Yasushi Goto, Satoshi Shiono, Shinichi Toyooka, Yoshimasa Maniwa, Toyofumi Fengshi Chen-Yoshikawa, Shun-ichi I. WATANABE, Masataka Taguri, Nodoka Seya, Tomonori Mizutani, Hideo Kunitoh, the Japan Cancer Treatment Optimization group (JACTOP), Norihiko Ikeda
26 views DOI Abstract
2026
Real-world incidence of interstitial lung disease with enfortumab vedotin plus pembrolizumab or enfortumab vedotin monotherapy in metastatic urothelial carcinoma: a multicenter retrospective study in Japan
Yuki Kobari, Nao Nakajima, AKIRA SAITO, Nanaka Katsurayama, TORU INAKAWA, Takanori Endo, Yuki Nemoto, Kazutaka Nakamura, Koichi Nishimura, Maki Yoshino, Hiroki Ishihara, Hironori Fukuda, Kazuhiko Yoshida, Hiroaki Shimmura, Yasunobu Hashimoto, Tsunenori Kondo, Hiroshi Kobayashi, Toshio Takagi
28 views DOI Abstract
2026
Longitudinal plasma osimertinib concentrations during treatment in patients with EGFR-mutant NSCLC: a prospective real-world study
Reiko Makihara Ando, Yuki Shinno, Yuki Katsuya, Keisuke Ikegami, Yukitaka Shibata, Makoto Maeda, Akiko Tateishi, Tomonori Mizutani, Yusuke Okuma, Tatsuya Yoshida, Hidehito Horinouchi, Noboru Yamamoto, Hironobu Hashimoto, Yasushi Goto
23 views DOI Abstract
2026
Early progression after immune checkpoint inhibition: aligning assessment with disease distribution
Murat Kiracı
15 views DOI Abstract
2026
Author’s reply to “Early progression after immune checkpoint inhibition: aligning assessment with disease distribution”
Hiroki Noda, Takuma Makino, Yuto Naoi, Shohei Fujimoto, Mizuo Ando
20 views DOI Abstract
2026
Correction to: Suicide risk among individuals diagnosed with cancer during versus before the COVID-19 pandemic: a nationwide population-based study
36 views DOI Abstract
2026
Identification of a prognostic signature based on expression of post-translational modification-related genes in acute myeloid leukemia
Donghui Gan, Jinfang Zeng, Jun Lin, Xiaojun Chen, Mengting Huang, Dan Weng, Jun Yan
63 views DOI Abstract
Journament Score
33.7/100 · Poor
Ranked #11,074 of 29,305 scored
(34,041 journals indexed)
Platform Statistics
AI Quality Analysis
Separate paid analysis — does not affect ranking.
Journament

Overall Quality Score

33.7/100

Tier: Poor

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

31.3/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

Not yet measured

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

16.7/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.5/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

8.6/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

80.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Content Distribution

25.6/100

Measures how evenly reader attention spreads across the journal's articles, using the Gini coefficient of article clicks.

Higher scores mean readership is distributed across many articles rather than concentrated on one or two.

Ethics & Transparency Score

Not yet measured

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

Not yet measured

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

Not yet measured

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

Not yet measured

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

Not yet measured

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.